Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation

Nafamostat, a serine proteinase inhibitor with various actions including antithrombin, antiplasmin, and antitrypsin effects, has been used in clinical practice to treat disseminated intravascular coagulation (DIC) and pancreatitis. This case report describes the clinical course of a patient with COV...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Infect Dis
Glavni autori: Takahashi, Wakana, Yoneda, Taro, Koba, Hayato, Ueda, Tsukasa, Tsuji, Noriaki, Ogawa, Haruhiko, Asakura, Hidesaku
Format: Artigo
Jezik:Inglês
Izdano: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7607231/
https://ncbi.nlm.nih.gov/pubmed/33157292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijid.2020.10.093
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items